![]() |
Volumn 333, Issue 6047, 2011, Pages 1248-1252
|
Synthetic biology moving into the clinic
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
BACTERIAL PROTEIN;
BETA LACTAM;
CTNNB1 PROTEIN;
INSULINOTROPIC PROTEIN;
INTERLEUKIN 2;
INVASIN;
OFLOXACIN;
QUINOLONE;
UNCLASSIFIED DRUG;
CANCER;
CYTOGENETICS;
INFECTIOUS DISEASE;
MOLECULAR ANALYSIS;
ANTIBACTERIAL ACTIVITY;
BACTERIAL CELL;
BACTERIAL STRAIN;
BACTERIOPHAGE;
BIOENGINEERING;
BIOFILM;
BIOMEDICINE;
CANCER THERAPY;
CELL THERAPY;
CLINICAL PRACTICE;
DRUG MANUFACTURE;
ESCHERICHIA COLI INFECTION;
GENE EXPRESSION;
GENE SILENCING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IN VITRO STUDY;
MICROBIOME;
NONHUMAN;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROTEIN EXPRESSION;
REVIEW;
SURVIVAL RATE;
SYNTHETIC BIOLOGY;
VIBRIO CHOLERAE;
VIRUS ATTENUATION;
VIRUS CAPSID;
ANIMALS;
BACTERIAL INFECTIONS;
CELL TRANSPLANTATION;
CULICIDAE;
GENE REGULATORY NETWORKS;
GENETIC ENGINEERING;
HUMANS;
INSECT VECTORS;
MALARIA;
METAGENOME;
NEOPLASMS;
REGENERATIVE MEDICINE;
SYNTHETIC BIOLOGY;
VACCINES, SYNTHETIC;
|
EID: 80052484996
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1206843 Document Type: Review |
Times cited : (332)
|
References (38)
|